首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   840篇
  免费   53篇
  国内免费   471篇
  2023年   8篇
  2022年   34篇
  2021年   22篇
  2020年   21篇
  2019年   48篇
  2018年   40篇
  2017年   78篇
  2016年   78篇
  2015年   56篇
  2014年   55篇
  2013年   23篇
  2012年   63篇
  2011年   48篇
  2010年   43篇
  2009年   44篇
  2008年   42篇
  2007年   40篇
  2006年   39篇
  2005年   27篇
  2004年   22篇
  2003年   32篇
  2002年   24篇
  2001年   38篇
  2000年   52篇
  1999年   54篇
  1998年   45篇
  1997年   34篇
  1996年   36篇
  1995年   37篇
  1994年   39篇
  1993年   11篇
  1992年   6篇
  1991年   3篇
  1990年   8篇
  1989年   8篇
  1988年   7篇
  1987年   10篇
  1986年   6篇
  1985年   4篇
  1984年   4篇
  1983年   47篇
  1982年   4篇
  1981年   3篇
  1980年   2篇
  1978年   2篇
  1970年   2篇
  1964年   2篇
  1963年   2篇
  1956年   2篇
  1953年   1篇
排序方式: 共有1364条查询结果,搜索用时 0 毫秒
71.
巨噬细胞浸润和激活是急性结肠炎的关键步骤。巨噬细胞中氧化还原介导的Nlrp3炎症小体激活在介导结肠炎症反应中起着关键作用。从大黄根茎中分离出的大黄酸具有较强的抗炎作用。然而,其在调节急性结肠炎症中的作用尚未得到研究。来自澳门大学的王一涛及其团队研究了大黄酸在急性肠道炎症期间的保护机制及其对巨噬细胞活化的调节。结果发现大黄酸通过Nlrp3炎症小体干扰其在巨噬细胞中的复合物组装,降低IL-1β的分泌。大黄酸还通过激活Nrf2-HO1-NQO1通路,抑制Nox2亚单位的表达和易位以调节氧化还原平衡。  相似文献   
72.
流感是一种急性呼吸道疾病,由甲型、乙型和丙型等流感病毒引起。其中,甲型和乙型流感病毒可导致季节性流行甚至全球大流行。流感病毒神经氨酸酶(NA)是病毒复制、传播和发病机制中的关键酶,因而研发神经氨酸酶抑制剂(NAIs)是对抗流感感染的有效途径之一。在中国,许多用于清热解毒的中药单独使用或作为中药配方来治疗流感显示出良好的疗效,但如何从中药中快速分离出活性物质是一个难题。  相似文献   
73.
卢聪聪  刘倩  黄晓磊 《生物多样性》2022,30(7):22204-216
完整的线粒体基因组已被广泛应用于分子进化、基因组学、系统发育等方面的研究。蚜虫是一类重要的农林业害虫, 但目前公开报道的蚜虫完整线粒体基因组非常有限, 因此获得更多的基因组数据对相关研究具有重要价值。本文报道了榕毛管蚜(Greenidea ficicola)、橘二叉蚜(Aphis aurantia)和油杉纩蚜(Mindarus keteleerifoliae) 3种蚜虫的完整线粒体基因组的序列、详细注释信息、基因结构图、密码子使用情况等。该数据集可为昆虫系统发育关系、种群分化格局、害虫防治等方面的工作提供帮助。  相似文献   
74.
75.
76.
77.
Here are the 18 guidance points contained in the UNAIDS document on Ethical Considerations in HIV Preventive Vaccine Research, reproduced by kind permission of the Joint United Nations Programme on HIV/AIDS (UNAIDS).  相似文献   
78.
A mutant human factor IX with arginine at 338 residual changed to alanine (hFIXR338A) by site-directed mutagenesis was introduced into AAV vectors, and a recombinant adeno-associ-ated viral vector containing hFIXR338A, prepared by rHSV/AAV hybrid helper virus system, was directly introduced to the hind leg muscle of factor IX knock out mice. The expression and the biological activity of human factor IX mutant, hFIXR338A, and the immune response against it in the treated mice were assayed and detected. The results showed that (i) the high-level expression of human factor IX mutant protein, hFIXR338A, has been detected in rAAV-hFIXR338A treated hemophilia B mice and lasted more than 15 weeks; (ii) the clotting activity of hFIXR338A in plasma is 34.2%± 5.23%, which is remarkably higher than that of (14.27%±3.4%) of wild type hFIX treated mice in the activated partial thromboplastin assay; (iii) immune response against factor IX R338A was absent, with no factor IX mutant protein (hFIXR338A) inhibitors deve  相似文献   
79.
The Limulus amoebocyte lysate (LAL) test has replaced about 80% of the use of the rabbit pyrogen test. Ideally, human-based in vitro tests are needed, to replace the remaining use of the rabbit test and the use of the LAL test. The progress of an EU-funded project is described, in which a number of in vitro tests, based on the human fever reaction are passing through a prevalidation study on the way to evaluation in a formal validation study.  相似文献   
80.
Lipid disorders and increased oxidative stress may exacerbate some complications of diabetes mellitus. Previous studies have implicated the beneficial effects of some antioxidants, omega-3 polyunsaturated fatty acids (PUFAs), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in the protection of cells from the destructive effect of increased lipids and lipid peroxidation products. This study, therefore, was designed to investigate the effects of cod liver oil (CLO, Lysi Ltd. Island), which comprises mainly vitamin A, PUFAs, EPA and DHA. Effects were monitored on plasma lipids, lipid peroxidation products (MDA) and the activities of antioxidant enzymes, glutathione peroxidase (GSHPx) and catalase in heart, liver, kidney and lung of non-diabetic control and streptozotocin (STZ)-induced-diabetic rats. Two days after STZ-injection (55 mg kg(-1) i.p.), non-diabetic control and diabetic rats were divided randomly into two groups as untreated or treated with CLO (0.5 ml kg(-1) rat per day) for 12 weeks. Plasma glucose, triacylglycerol and cholesterol concentrations were significantly elevated in 12-week untreated-diabetic animals; CLO treatment almost completely prevented these abnormalities in triacylglycerol and cholesterol, but hyperglycaemia was partially controlled. CLO also provided better weight gain in diabetic animals. In untreated diabetic rats, MDA markedly increased in aorta, heart and liver but was not significantly changed in kidney and lung. This was accompanied by a significant increase in both GSHPx and catalase enzyme activities in aorta, heart, and liver of diabetic rats. In kidney and lung, diabetes resulted in reduced catalase while GSHPx was significantly activated. In aorta, heart, and liver, diabetes-induced changes in MDA were entirely prevented by CLO treatment. In the tissues of CLO-treated diabetic animals, GSHPx activity paralleled those of control animals. CLO treatment also caused significant improvements in catalase activities in every tissue of diabetic rats, but failed to affect MDA and antioxidant activity in control animals. The current study suggests that the treatment of diabetic rats with CLO provides better control of glucose and lipid metabolism, allows recovery of normal growth rate, prevents oxidative/peroxidative stress and ameliorates endogenous antioxidant enzyme activities in various tissues. Because CLO contains a plethora of beneficial compounds together, its use for the management of diabetes-induced complications may provide important advantages.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号